Home | About PR | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |   Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 12  |  Issue : 1  |  Page : 53-59

Novel phytocompounds from vernonia amygdalina with antimalarial potentials


1 Department of Pharmaceutical Sciences, Pharmacognosy Research Laboratory, Dibrugarh University, Dibrugarh, Assam, India
2 Department of Pharmacognosy and Phytochemistry, Phytochemistry Research Laboratory, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India

Correspondence Address:
Dr. InnocentMary IfedibaluChukwu Ejiofor
Department of Pharmaceutical Sciences, Pharmacognosy Research Laboratory, Dibrugarh University, Dibrugarh . 786 004, Assam
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/pr.pr_81_19

Rights and Permissions

Background: Malaria, one of the diseases predominant in the African continent, has been reported to be treated with plants and also some in vitro and in vivo tests have supported this. Vernonia amygdalina belonging to the family of Asteraceae is one of the plants widely used in Nigeria and studied for treatment of malaria and some scientific researchers have validated this claim. Objectives: In the present study, we aimed at isolation of possible compounds from the methanolic stem-bark of V. amygdalina, elucidation and characterization of the isolated compounds, and carry out antimalarial evaluations of the isolated compounds. Materials and Methods: Isolation of compounds was done using column chromatography technique, elucidation and characterization were done based on infrared, Mass,1H, and13C nuclear magnetic resonance spectra. The in vitro antimalarial activity was carried out on the ring stage of the malaria parasite cycle of chloroquine-sensitive (3D7) and chloroquine-resistant (Dd2) strains. Results: Five novel compounds were isolated; 4α-Hydroxy-n-pentadecanoic acid (CC7), 11α- Hydroxyurs-5,12-dien- 28-oic acid-3α, 25-olide (CC10), 1-Heneicosanol-O-β-D-glucopyranoside (CC19), 10-Geranilanyl-O-β-D-xyloside (AC2A), 6β,10β,14β-Trimethyl heptadecan-15α-olyl-15-O-β-D-glucopyranosyl-1,5β-olide (CC14), and one new compound; Glucuronolactone (CC3). The compounds CC10, CC19, AC2A, CC14, and CC3 recorded schizont inhibition at different percentages. Compounds CC19, AC2A, and CC14 recorded half-maximal inhibitory concentration (IC50) values of 10.55 μg/ml, 12.56 μg/ml, and 11.68 μg/ml, respectively. Conclusion: The IC50values obtained are much higher than that of chloroquine, which is 0.02 μg/ml. These compounds showed antimalarial activity at different levels. The presence and effect of these compounds validate the use of this plant for the treatment of malaria in the traditional medicinal practice of Nigeria.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed290    
    Printed7    
    Emailed0    
    PDF Downloaded33    
    Comments [Add]    

Recommend this journal